73 related articles for article (PubMed ID: 1981852)
1. Zolantidine-induced attenuation of morphine antinociception in rhesus monkeys.
Hough LB; Nalwalk JW; Battles AH
Brain Res; 1990 Aug; 526(1):153-5. PubMed ID: 1981852
[TBL] [Abstract][Full Text] [Related]
2. Importance of histamine H2 receptors in restraint-morphine interactions.
Nalwalk JW; Hough LB
Life Sci; 1995; 57(13):PL153-8. PubMed ID: 7674814
[TBL] [Abstract][Full Text] [Related]
3. Modulation of morphine antinociception by the brain-penetrating H2 antagonist zolantidine: detailed characterization in five nociceptive test systems.
Nalwalk JW; Koch JE; Barke KE; Bodnar RJ; Hough LB
Pharmacol Biochem Behav; 1995 Mar; 50(3):421-9. PubMed ID: 7617681
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of morphine antinociception by centrally administered histamine H2 receptor antagonists.
Hough LB; Nalwalk JW
Eur J Pharmacol; 1992 Apr; 215(1):69-74. PubMed ID: 1355443
[TBL] [Abstract][Full Text] [Related]
5. A role for histamine and H2-receptors in opioid antinociception.
Gogas KR; Hough LB; Eberle NB; Lyon RA; Glick SD; Ward SJ; Young RC; Parsons ME
J Pharmacol Exp Ther; 1989 Aug; 250(2):476-84. PubMed ID: 2547933
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of 2-deoxy-D-glucose antinociception, but not hyperphagia by zolantidine, a histamine (H2) receptor antagonist.
Koch JE; Hough LB; Bodnar RJ
Pharmacol Biochem Behav; 1992 Feb; 41(2):371-6. PubMed ID: 1349437
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of naloxone-resistant antinociception by centrally administered H2-antagonists.
Gogas KR; Hough LB
J Pharmacol Exp Ther; 1989 Jan; 248(1):262-7. PubMed ID: 2563290
[TBL] [Abstract][Full Text] [Related]
8. Effects of zolantidine a brain-penetrating H2-receptor antagonist, on naloxone-sensitive and naloxone-resistant analgesia.
Gogas KR; Hough LB
Neuropharmacology; 1988 Apr; 27(4):357-62. PubMed ID: 2901671
[TBL] [Abstract][Full Text] [Related]
9. Effects of the histaminergic system on the morphine-induced conditioned place preference in mice.
Suzuki T; Takamori K; Misawa M; Onodera K
Brain Res; 1995 Mar; 675(1-2):195-202. PubMed ID: 7796129
[TBL] [Abstract][Full Text] [Related]
10. Sleep variables are unaltered by zolantidine in rats: are histamine H2-receptors not involved in sleep regulation?
Monti JM; Orellana C; Boussard M; Jantos H; Olivera S
Brain Res Bull; 1990 Aug; 25(2):229-31. PubMed ID: 1977498
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.
Hough LB; Nalwalk JW; Lu Q; Shan Z; Svokos K; Wentland MP; Montero MJ
Eur J Pharmacol; 2005 Oct; 522(1-3):38-46. PubMed ID: 16216240
[TBL] [Abstract][Full Text] [Related]
12. Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist.
Calcutt CR; Ganellin CR; Griffiths R; Leigh BK; Maguire JP; Mitchell RC; Mylek ME; Parsons ME; Smith IR; Young RC
Br J Pharmacol; 1988 Jan; 93(1):69-78. PubMed ID: 2894879
[TBL] [Abstract][Full Text] [Related]
13. H2-receptor-mediated stress-induced analgesia is dependent on neither pituitary nor adrenal activation.
Gogas KR; Hough LB
Pharmacol Biochem Behav; 1988 Jul; 30(3):791-4. PubMed ID: 2905473
[TBL] [Abstract][Full Text] [Related]
14. Actions of the brain-penetrating H2-antagonist zolantidine on histamine dynamics and metabolism in rat brain.
Hough LB; Jackowski S; Eberle N; Gogas KR; Camarota NA; Cue D
Biochem Pharmacol; 1988 Dec; 37(24):4707-11. PubMed ID: 3202904
[TBL] [Abstract][Full Text] [Related]
15. Activity of the new histamine H2-receptor antagonist zolantidine at cardiac and gastric H2-receptors.
Coruzzi G; Adami M; Pozzoli C; Poli E; Bertaccini G
Pharmacology; 1994 Feb; 48(2):69-76. PubMed ID: 7907797
[TBL] [Abstract][Full Text] [Related]
16. Further study on the effects of histamine H2 receptor agonist and antagonists on restraint-induced antinociception in mice.
Wong JC
Methods Find Exp Clin Pharmacol; 1999; 21(6):403-7. PubMed ID: 10445232
[TBL] [Abstract][Full Text] [Related]
17. Modulation of morphine antinociception by antagonism of H2 receptors in the periaqueductal gray.
Hough LB; Nalwalk JW
Brain Res; 1992 Aug; 588(1):58-66. PubMed ID: 1356588
[TBL] [Abstract][Full Text] [Related]
18. Different effects of the histamine H2 receptor blockers, famotidine and zolantidine, on the human atrium in vitro.
Poli E; Pozzoli C; Barboso G; Bertaccini G
Arch Int Pharmacodyn Ther; 1994; 328(2):180-90. PubMed ID: 7710303
[TBL] [Abstract][Full Text] [Related]
19. Effects of a histamine H2 receptor agonist and antagonist on restraint-induced antinociception in female mice.
Wong CL
Eur J Pharmacol; 1995 Jun; 279(2-3):109-13. PubMed ID: 7556390
[TBL] [Abstract][Full Text] [Related]
20. Two histamine H2 receptor antagonists, zolantidine and cimetidine, modulate nociception in cholestatic rats.
Hasanein P
J Psychopharmacol; 2011 Feb; 25(2):281-8. PubMed ID: 19825905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
